Circulating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker

OBJECTIVE: Myasthenia gravis (MG) is a chronic autoimmune disorder where autoantibodies target the nicotinic acetylcholine receptors (AChR+) in about 85% of cases, in which the thymus is considered to play a pathogenic role. As there are no reliable biomarkers to monitor disease status in MG, we ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Punga, Tanel, Le Panse, Rozen, Andersson, Mats, Truffault, Frédérique, Berrih-Aknin, Sonia, Punga, Anna R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207504/
https://www.ncbi.nlm.nih.gov/pubmed/25356381
http://dx.doi.org/10.1002/acn3.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207504/
https://www.ncbi.nlm.nih.gov/pubmed/25356381
http://dx.doi.org/10.1002/acn3.24

Ejemplares similares